AI Verdict
MKL has stronger fundamentals based on our AI analysis.
MKL vs MIRM Fundamental Comparison
| Metric | MKL | MIRM |
|---|---|---|
| Revenue | $15.5B | $521.3M |
| Net Income | $2.1B | $-23.4M |
| Net Margin | 13.6% | -4.5% |
| ROE | 11.3% | -7.4% |
| ROA | 3.1% | -2.8% |
| Current Ratio | N/A | 2.67x |
| Debt/Equity | 0.23x | 0.00x |
| EPS | $169.22 | $-0.47 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MKL vs MIRM: Frequently Asked Questions
Is MKL or MIRM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MKL has stronger fundamentals. MKL is rated BUY (78% confidence) while MIRM is rated HOLD (62% confidence). This is not investment advice.
How does MKL compare to MIRM fundamentally?
MARKEL GROUP INC. has ROE of 11.3% vs Mirum Pharmaceuticals, Inc.'s -7.4%. Net margins are 13.6% vs -4.5% respectively.
Which stock pays higher dividends, MKL or MIRM?
MKL has a dividend yield of N/A or no dividend while MIRM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MKL or MIRM for long term?
For long-term investing, consider that MKL has BUY rating with 78% confidence, while MIRM has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MKL vs MIRM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MKL vs MIRM, the AI consensus favors MKL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.